Balance Sheet Nutrien Ltd.

Equities

NTR

CA67077M1086

Agricultural Chemicals

Market Closed - Toronto S.E. Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
113.79 ^CAD	-0.54%		+9.90%	+34.31%

03-13	NUTRIEN : RBC maintains a Buy rating	ZD
03-13	Wells Fargo Upgrades Nutrien to Overweight From Equalweight, Adjusts Price Target to CA$136.26 From CA$105.46	MT

3468bd7b2583e82d.76SxpOL1igixUXAGxPMe0dVgSD8xQzGGXt_qN1WXWdI.pImIk4-441jnYiFj8sozvowmMlB1G130K7CEfGHwPOCE5f_wuqq6XMMcMQ

Published financial data: NUTRIEN LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	26.86B	37.01B	28.08B	25.02B	25.95B
Total Revenues	26.86B	37.01B	28.08B	25.02B	25.95B
Cost of Goods Sold, Total	17.45B	21.59B	19.61B	17.49B	17.6B
Gross Profit	9.41B	15.42B	8.47B	7.53B	8.35B
Selling General & Admin Expenses, Total	3.63B	3.99B	4.03B	4.08B	3.92B
Stock-Based Compensation (IS)	198M	63M	-14M	37M	163M
Other Operating Expenses	737M	1.53B	907M	816M	790M
Other Operating Expenses, Total	4.56B	5.58B	4.92B	4.94B	4.88B
Operating Income	4.85B	9.84B	3.55B	2.59B	3.47B
Interest Expense, Total	-479M	-484M	-726M	-683M	-675M
Interest And Investment Income	8M	25M	35M	28M	51M
Net Interest Expenses	-471M	-459M	-691M	-655M	-624M
Income (Loss) On Equity Invest.	89M	247M	101M	130M	37M
Currency Exchange Gains (Loss)	-42M	-31M	-91M	-360M	-9M
Other Non Operating Income (Expenses)	9M	-96M	-97M	-60M	-59M
EBT, Excl. Unusual Items	4.43B	9.5B	2.78B	1.65B	2.82B
Restructuring Charges	-	-	-	-47M	-68M
Merger & Related Restructuring Charges	-43M	-46M	-49M	-	-
Gain (Loss) On Sale Of Investments	-	19M	-	-	301M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-33M	780M	-774M	-530M	-
Insurance Settlements	-	-	-	65M	1M
Other Unusual Items	-187M	-8M	-	-	-
EBT, Incl. Unusual Items	4.17B	10.25B	1.95B	1.14B	3.05B
Income Tax Expense	989M	2.56B	670M	436M	752M
Earnings From Continuing Operations	3.18B	7.69B	1.28B	700M	2.3B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	3.18B	7.69B	1.28B	700M	2.3B
Minority Interest	-26M	-27M	-24M	-26M	-30M
Net Income - (IS)	3.15B	7.66B	1.26B	674M	2.27B
Net Income to Common Incl Extra Items	3.15B	7.66B	1.26B	674M	2.27B
Net Income to Common Excl. Extra Items	3.15B	7.66B	1.26B	674M	2.27B
Per Share Items
Net EPS - Basic	5.53	14.23	2.53	1.36	4.66
Basic EPS - Continuing Operations	5.53	14.23	2.53	1.36	4.66
Basic Weighted Average Shares Outstanding	570M	538M	496M	494M	486M
Net EPS - Diluted	5.52	14.18	2.53	1.36	4.66
Diluted EPS - Continuing Operations	5.52	14.18	2.53	1.36	4.66
Diluted Weighted Average Shares Outstanding	571M	540M	497M	494M	487M
Normalized Basic EPS	4.82	10.98	3.45	2.03	3.56
Normalized Diluted EPS	4.8	10.95	3.44	2.03	3.55
Dividend Per Share	1.84	1.92	2.12	2.16	2.18
Payout Ratio	33.14	13.46	82.03	157.27	46.8
Supplemental Items
EBITDA	6.49B	11.51B	5.33B	4.51B	5.41B
EBITA	5.16B	10.21B	3.9B	2.93B	3.77B
EBIT	4.85B	9.84B	3.55B	2.59B	3.47B
EBITDAR	6.57B	11.61B	5.44B	4.62B	5.51B
Effective Tax Rate - (Ratio)	23.73	24.98	34.32	38.38	24.66
Total Current Taxes	1.02B	2.38B	663M	405M	502M
Total Deferred Taxes	-31M	182M	7M	31M	250M
Normalized Net Income	2.74B	5.91B	1.71B	1B	1.73B
Interest Capitalized	29M	37M	71M	82M	71M
Interest on Long-Term Debt	448M	368M	494M	542M	568M
Non-Cash Pension Expense	19M	16M	-67M	-1M	4M
Supplemental Operating Expense Items
Selling and Marketing Expenses	3.14B	3.41B	3.4B	3.44B	3.32B
General and Administrative Expenses	477M	565M	626M	644M	600M
Research And Development Expense From Footnotes	69M	122M	114M	124M	114M
Net Rental Expense, Total	81M	93M	103M	110M	102M
Imputed Operating Lease Interest Expense	29.65M	34.04M	53.62M	53.06M	49.04M
Imputed Operating Lease Depreciation	51.35M	58.96M	49.38M	56.94M	52.96M
Stock-Based Comp., Other (Total)	198M	63M	-14M	37M	163M
Total Stock-Based Compensation	198M	63M	-14M	37M	163M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	499M	901M	941M	853M	701M
Total Cash And Short Term Investments	499M	901M	941M	853M	701M
Accounts Receivable, Total	4.7B	5.6B	4.67B	4.64B	5.08B
Other Receivables	661M	598M	730M	755M	595M
Total Receivables	5.37B	6.19B	5.4B	5.39B	5.68B
Inventory	6.33B	7.63B	6.34B	6.15B	6.98B
Prepaid Expenses	1.65B	1.62B	1.5B	1.4B	1.4B
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	13.85B	16.34B	14.17B	13.79B	14.75B
Gross Property Plant And Equipment	34.82B	37.22B	39.32B	40.67B	42.29B
Accumulated Depreciation	-14.8B	-15.46B	-16.86B	-18.07B	-19.54B
Net Property Plant And Equipment	20.02B	21.77B	22.46B	22.6B	22.75B
Long-term Investments	703M	843M	736M	698M	144M
Goodwill	12.22B	12.37B	12.11B	12.04B	12.14B
Other Intangibles, Total	2.34B	2.3B	2.22B	1.82B	1.67B
Deferred Tax Assets Long-Term	262M	448M	477M	401M	276M
Deferred Charges Long-Term	88M	104M	113M	126M	125M
Other Long-Term Assets, Total	479M	417M	461M	357M	457M
Total Assets	49.95B	54.59B	52.75B	51.84B	52.3B
Liabilities
Accounts Payable, Total	5.18B	5.8B	5.48B	5.36B	5.54B
Accrued Expenses, Total	1.74B	1.78B	1.45B	1.28B	1.35B
Short-term Borrowings	1.56B	2.14B	1.82B	1.53B	873M
Current Portion of Long-Term Debt	545M	542M	512M	1.04B	513M
Current Portion of Leases	286M	305M	327M	356M	346M
Current Income Taxes Payable	606M	899M	14M	22M	20M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	2.53B	2.81B	2.53B	2.45B	2.4B
Total Current Liabilities	12.44B	14.28B	12.12B	12.04B	11.04B
Long-Term Debt	7.52B	8.04B	8.91B	8.88B	9.35B
Long-Term Leases	934M	899M	999M	999M	937M
Pension & Other Post Retirement Benefits	419M	319M	252M	227M	221M
Deferred Tax Liability Non Current	3.16B	3.55B	3.57B	3.54B	3.67B
Other Non Current Liabilities	1.77B	1.64B	1.69B	1.71B	1.72B
Total Liabilities	26.26B	28.72B	27.55B	27.4B	26.94B
Common Stock, Total	15.46B	14.17B	13.84B	13.75B	13.52B
Additional Paid In Capital	149M	109M	83M	68M	57M
Retained Earnings	8.19B	11.93B	11.53B	11.11B	12.08B
Comprehensive Income and Other	-146M	-391M	-296M	-515M	-329M
Total Common Equity	23.65B	25.82B	25.16B	24.41B	25.32B
Minority Interest	47M	45M	45M	35M	42M
Total Equity	23.7B	25.86B	25.2B	24.44B	25.36B
Total Liabilities And Equity	49.95B	54.59B	52.75B	51.84B	52.3B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	551M	499M	495M	489M	481M
ECS Total Common Shares Outstanding	557M	507M	495M	491M	482M
Book Value / Share	42.43	50.9	50.87	49.71	52.54
Tangible Book Value	9.09B	11.15B	10.82B	10.54B	11.52B
Tangible Book Value Per Share	16.31	21.99	21.89	21.48	23.9
Total Debt	10.85B	11.93B	12.57B	12.81B	12.02B
Net Debt	10.35B	11.03B	11.62B	11.95B	11.32B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-72M	-75M	-44M	-56M	-60M
Debt Equivalent Oper. Leases	648M	744M	824M	880M	816M
Minority Interest, Total (Incl. Fin. Div)	47M	45M	45M	35M	42M
Equity Method Investments, Total	459M	643M	482M	477M	134M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	823M	951M	884M	892M	980M
Inventories - Work In Process, Total	206M	184M	160M	154M	184M
Inventories - Finished Goods, Total	5.3B	6.5B	5.29B	5.1B	5.81B
Land - (BS)	1.55B	1.6B	1.63B	1.73B	1.94B
Buildings, Total	8.58B	8.8B	9.05B	9.19B	9.37B
Machinery, Total	20.63B	22.02B	23.24B	24.42B	25.57B
Full Time Employees	23.5K	24.7K	25.9K	25.5K	-
Accumulated Allowance for Doubtful Accounts (Supple)	82M	95M	111M	167M	197M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	3.15B	7.66B	1.26B	674M	2.27B
Depreciation & Amortization - CF	1.64B	1.64B	1.83B	2B	2.07B
Amortization of Goodwill and Intangible Assets - (CF)	314M	368M	342M	341M	298M
Depreciation & Amortization, Total	1.95B	2.01B	2.17B	2.34B	2.37B
(Gain) Loss on Sale of Investments - (CF)	-	-19M	-	-	-301M
Asset Writedown & Restructuring Costs	33M	-780M	774M	530M	-
(Income) Loss On Equity Investments - (CF)	-	-181M	117M	-8M	65M
Stock-Based Compensation (CF)	198M	63M	-14M	37M	163M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	212M	503M	255M	450M	227M
Change In Accounts Receivable	-1.67B	-919M	879M	-224M	-128M
Change In Inventories	-1.46B	-1.28B	1.38B	60M	-557M
Change In Accounts Payable	1.69B	938M	-1.75B	-323M	-98M
Change in Other Net Operating Assets	-227M	114M	-	-	-
Cash from Operations	3.89B	8.11B	5.07B	3.54B	4.01B
Capital Expenditure	-1.68B	-2.23B	-2.46B	-2B	-1.86B
Cash Acquisitions	-88M	-407M	-153M	-21M	-23M
Divestitures	-	-	-92M	-	-
Sale (Purchase) of Intangible assets	-107M	-211M	-206M	-155M	-145M
Investment in Marketable and Equity Securities, Total	-	-	-	-68M	711M
Other Investing Activities, Total	64M	-56M	-42M	110M	-55M
Cash from Investing	-1.81B	-2.9B	-2.96B	-2.13B	-1.37B
Short Term Debt Issued, Total	1.34B	529M	-	-	-
Long-Term Debt Issued, Total	86M	1.04B	1.5B	1.02B	998M
Total Debt Issued	1.43B	1.57B	1.5B	1.02B	998M
Short Term Debt Repaid, Total	-	-	-458M	-142M	-696M
Long-Term Debt Repaid, Total	-2.53B	-902M	-1.02B	-1.06B	-1.51B
Total Debt Repaid	-2.53B	-902M	-1.48B	-1.2B	-2.2B
Issuance of Common Stock	200M	168M	33M	18M	38M
Repurchase of Common Stock	-1.04B	-4.52B	-1.05B	-184M	-551M
Common Dividends Paid	-1.04B	-1.03B	-1.03B	-1.06B	-1.06B
Common & Preferred Stock Dividends Paid	-1.04B	-1.03B	-1.03B	-1.06B	-1.06B
Other Financing Activities, Total	-21M	-20M	-34M	-46M	-37M
Cash from Financing	-3B	-4.73B	-2.06B	-1.45B	-2.82B
Foreign Exchange Rate Adjustments	-31M	-76M	-7M	-37M	30M
Net Change in Cash	-955M	402M	40M	-88M	-152M
Supplemental Items
Cash Interest Paid	491M	482M	729M	740M	738M
Cash Income Tax Paid (Refund)	435M	1.88B	1.76B	321M	335M
Levered Free Cash Flow	1.76B	4.63B	1.64B	1.36B	1.36B
Unlevered Free Cash Flow	2.06B	4.93B	2.09B	1.78B	1.78B
Change In Net Working Capital	1.34B	855M	-388M	59M	918M
Net Debt Issued / Repaid	-1.1B	672M	19M	-181M	-1.21B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.24	11.77	4.14	3.1	4.16
Return on Total Capital	8.87	17	5.88	4.32	5.81
Return On Equity %	13.79	31.02	5.02	2.82	9.22
Return on Common Equity	13.7	30.97	4.94	2.72	9.12
Margin Analysis
Gross Profit Margin %	35.03	41.67	30.18	30.1	32.17
SG&A Margin	13.51	10.77	14.34	16.33	15.12
EBITDA Margin %	24.16	31.11	18.99	18.04	20.86
EBITA Margin %	19.21	27.58	13.87	11.73	14.52
EBIT Margin %	18.04	26.59	12.65	10.37	13.37
Income From Continuing Operations Margin %	11.84	20.77	4.57	2.8	8.85
Net Income Margin %	11.74	20.7	4.48	2.69	8.74
Net Avail. For Common Margin %	11.74	20.7	4.48	2.69	8.74
Normalized Net Income Margin	10.21	15.97	6.09	4.01	6.66
Levered Free Cash Flow Margin	6.55	12.51	5.84	5.42	5.23
Unlevered Free Cash Flow Margin	7.66	13.33	7.45	7.13	6.85
Asset Turnover
Asset Turnover	0.55	0.71	0.52	0.48	0.5
Fixed Assets Turnover	1.35	1.77	1.27	1.11	1.14
Receivables Turnover (Average Receivables)	6.96	7.19	5.47	5.38	5.34
Inventory Turnover (Average Inventory)	3.1	3.09	2.81	2.8	2.68
Short Term Liquidity
Current Ratio	1.11	1.14	1.17	1.15	1.34
Quick Ratio	0.47	0.5	0.52	0.52	0.58
Operating Cash Flow to Current Liabilities	0.31	0.57	0.42	0.29	0.36
Days Sales Outstanding (Average Receivables)	52.48	50.79	66.7	68.05	68.33
Days Outstanding Inventory (Average Inventory)	117.73	118.01	130.01	130.65	136.08
Average Days Payable Outstanding	92.89	87.5	112.36	114.64	107.92
Cash Conversion Cycle (Average Days)	77.32	81.3	84.35	84.07	96.49
Long Term Solvency
Total Debt/Equity	45.77	46.12	49.86	52.4	47.38
Total Debt / Total Capital	31.4	31.56	33.27	34.38	32.15
LT Debt/Equity	35.68	34.56	39.33	40.42	40.56
Long-Term Debt / Total Capital	24.48	23.65	26.25	26.52	27.52
Total Liabilities / Total Assets	52.56	52.62	52.22	52.85	51.5
EBIT / Interest Expense	10.12	20.33	4.89	3.8	5.14
EBITDA / Interest Expense	14.19	24.49	7.88	7.22	8.65
(EBITDA - Capex) / Interest Expense	10.69	19.89	4.49	4.29	5.89
Total Debt / EBITDA	1.6	1.01	2.2	2.6	2.06
Net Debt / EBITDA	1.52	0.93	2.03	2.42	1.94
Total Debt / (EBITDA - Capex)	2.12	1.24	3.86	4.37	3.02
Net Debt / (EBITDA - Capex)	2.02	1.15	3.57	4.08	2.84
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	33.95	37.79	-24.13	-10.92	3.73
Gross Profit, 1 Yr. Growth %	79.6	63.93	-45.06	-11.14	10.85
EBITDA, 1 Yr. Growth %	100.8	77.4	-53.67	-15.41	19.95
EBITA, 1 Yr. Growth %	185.87	97.83	-61.84	-24.67	28.43
EBIT, 1 Yr. Growth %	218.4	103.05	-63.89	-27.02	33.82
Earnings From Cont. Operations, 1 Yr. Growth %	592.59	141.81	-83.32	-45.4	228.14
Net Income, 1 Yr. Growth %	586.93	142.94	-83.58	-46.42	236.35
Normalized Net Income, 1 Yr. Growth %	310.22	115.47	-71.07	-41.3	72.25
Diluted EPS Before Extra, 1 Yr. Growth %	585.08	156.88	-82.16	-46.25	242.65
Accounts Receivable, 1 Yr. Growth %	55.85	18.94	-16.58	-0.71	9.6
Inventory, 1 Yr. Growth %	28.36	20.61	-16.98	-2.97	13.48
Net Property, Plant and Equip., 1 Yr. Growth %	1.81	8.75	3.19	0.64	0.63
Total Assets, 1 Yr. Growth %	5.85	9.27	-3.37	-1.72	0.89
Tangible Book Value, 1 Yr. Growth %	16.88	22.67	-2.94	-2.59	9.25
Common Equity, 1 Yr. Growth %	5.75	9.16	-2.56	-2.98	3.75
Cash From Operations, 1 Yr. Growth %	16.94	108.7	-37.53	-30.22	13.35
Capital Expenditures, 1 Yr. Growth %	17.78	25.32	9.41	-16.5	-6.95
Levered Free Cash Flow, 1 Yr. Growth %	-0.23	177.65	-64.31	-20.65	-0.06
Unlevered Free Cash Flow, 1 Yr. Growth %	-0.07	152.05	-57.25	-17.56	-0.33
Dividend Per Share, 1 Yr. Growth %	2.22	4.35	10.42	1.89	0.93
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.92	35.86	2.25	-17.79	-3.87
Gross Profit, 2 Yr. CAGR %	30.77	71.58	-5.1	-30.13	-0.75
EBITDA, 2 Yr. CAGR %	34.16	88.74	-9.34	-37.4	0.73
EBITA, 2 Yr. CAGR %	49.72	137.81	-13.12	-46.39	-1.64
EBIT, 2 Yr. CAGR %	54.09	154.27	-14.37	-48.67	-1.18
Earnings From Cont. Operations, 2 Yr. CAGR %	79.02	309.23	-36.5	-69.82	33.86
Net Income, 2 Yr. CAGR %	78.28	308.52	-36.83	-70.34	34.24
Normalized Net Income, 2 Yr. CAGR %	69.6	197.31	-21.04	-58.79	0.55
Diluted EPS Before Extra, 2 Yr. CAGR %	80.2	319.51	-32.3	-69.03	35.72
Accounts Receivable, 2 Yr. CAGR %	24.26	36.15	-0.39	-8.99	4.32
Inventory, 2 Yr. CAGR %	12.78	24.42	0.06	-10.25	4.94
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.79	5.22	5.93	1.9	0.63
Total Assets, 2 Yr. CAGR %	3.32	7.55	2.76	-2.55	-0.43
Tangible Book Value, 2 Yr. CAGR %	3.7	19.74	9.11	-2.76	3.16
Common Equity, 2 Yr. CAGR %	1.7	7.44	3.13	-2.77	0.33
Cash From Operations, 2 Yr. CAGR %	2.97	56.22	14.18	-33.98	-11.06
Capital Expenditures, 2 Yr. CAGR %	-1.52	25.1	17.78	-5.81	-11.86
Levered Free Cash Flow, 2 Yr. CAGR %	28.23	62.08	-0.86	-45.65	-10.95
Unlevered Free Cash Flow, 2 Yr. CAGR %	22.31	54.76	3.41	-39.64	-9.35
Dividend Per Share, 2 Yr. CAGR %	2.25	3.28	7.34	6.07	1.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.69	24.21	11.88	-2.34	-11.16
Gross Profit, 3 Yr. CAGR %	20.39	41	17.39	-7.16	-18.51
EBITDA, 3 Yr. CAGR %	19.92	47.25	18.18	-11.41	-22.25
EBITA, 3 Yr. CAGR %	28.57	64.29	29.22	-17.15	-28.27
EBIT, 3 Yr. CAGR %	30.69	68.93	32.66	-18.82	-29.35
Earnings From Cont. Operations, 3 Yr. CAGR %	368.07	97.89	40.83	-39.61	-33.14
Net Income, 3 Yr. CAGR %	-4.08	97.65	39.94	-40.21	-33.36
Normalized Net Income, 3 Yr. CAGR %	37.24	83.69	36.75	-28.47	-33.61
Diluted EPS Before Extra, 3 Yr. CAGR %	379.72	102.8	46.43	-37.31	-30.99
Accounts Receivable, 3 Yr. CAGR %	19.66	22.46	15.64	-0.5	-3.17
Inventory, 3 Yr. CAGR %	8.77	15.33	8.72	-0.96	-2.95
Net Property, Plant and Equip., 3 Yr. CAGR %	2.12	2.29	4.54	4.14	1.48
Total Assets, 3 Yr. CAGR %	3.16	5.26	3.78	1.24	-1.42
Tangible Book Value, 3 Yr. CAGR %	-5.53	9.67	11.64	5.07	1.08
Common Equity, 3 Yr. CAGR %	-1.07	4.13	4	1.05	-0.64
Cash From Operations, 3 Yr. CAGR %	23.72	30.31	15.09	-3.11	-20.94
Capital Expenditures, 3 Yr. CAGR %	6.06	8.82	20.1	4	-6.19
Levered Free Cash Flow, 3 Yr. CAGR %	23.12	62.98	-2.39	-6.64	-33.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	18.14	53.05	0.54	-3.04	-28.65
Dividend Per Share, 3 Yr. CAGR %	4.12	2.94	5.61	5.49	4.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	46.94	55.97	8.39	5.31	5.29
Gross Profit, 5 Yr. CAGR %	60.73	72.87	9.46	6.48	9.76
EBITDA, 5 Yr. CAGR %	39.83	54.88	7.23	4.58	10.86
EBITA, 5 Yr. CAGR %	57.47	75.39	9.91	4.97	15.86
EBIT, 5 Yr. CAGR %	56.33	74.97	10.35	4.9	17.92
Earnings From Cont. Operations, 5 Yr. CAGR %	74.06	118.6	110.53	-6.74	38
Net Income, 5 Yr. CAGR %	57.73	87.9	-18.84	-7.44	37.63
Normalized Net Income, 5 Yr. CAGR %	69.04	92.26	10.02	1.03	20.93
Diluted EPS Before Extra, 5 Yr. CAGR %	87.66	139.49	119.19	-4.36	42.05
Accounts Receivable, 5 Yr. CAGR %	61.59	70.36	11.2	8.75	10.97
Inventory, 5 Yr. CAGR %	52.47	57.48	5.2	4.32	7.19
Net Property, Plant and Equip., 5 Yr. CAGR %	8.49	10.91	3.63	2.14	2.96
Total Assets, 5 Yr. CAGR %	23.69	26.28	3	2.07	2.08
Tangible Book Value, 5 Yr. CAGR %	2.54	6.51	0.08	4.52	8.17
Common Equity, 5 Yr. CAGR %	23.6	25.47	0.59	1.31	2.52
Cash From Operations, 5 Yr. CAGR %	25.26	45.94	19.81	-0.72	3.81
Capital Expenditures, 5 Yr. CAGR %	13.42	27.89	11.9	2.96	5.5
Levered Free Cash Flow, 5 Yr. CAGR %	42.82	25.75	11.71	4.88	-5.11
Unlevered Free Cash Flow, 5 Yr. CAGR %	62.86	29.68	10.89	5.33	-2.9
Dividend Per Share, 5 Yr. CAGR %	21.32	36.85	5.4	4.18	3.91